Location History:
- Torino, IT (2015)
- Turin, IT (2013 - 2022)
Company Filing History:
Years Active: 2013-2022
Title: Maria Chiara Deregibus: Innovator in Extracellular Vesicle Research
Introduction
Maria Chiara Deregibus is a prominent inventor based in Turin, Italy. She has made significant contributions to the field of biomedical research, particularly in the isolation and application of extracellular vesicles (EVs). With a total of 3 patents to her name, her work has the potential to impact various medical applications.
Latest Patents
One of her latest patents focuses on the isolation of extracellular vesicles (EVs) from biological fluid samples. This invention relates to compositions and methods that enhance the recovery and enrichment of EVs, which are crucial for various biological processes. The methods utilize a combination of a polycation with an extracellular matrix-forming polymer, resulting in a cost-effective and efficient isolation process. Another notable patent involves the use of microvesicles (MVs) derived from stem cells for preparing a medicament aimed at the regeneration of damaged tissues or organs. This invention addresses the need for effective treatments for conditions such as acute renal failure and acute hepatic failure.
Career Highlights
Throughout her career, Maria Chiara Deregibus has worked with notable companies, including Fresenius Medical Care Deutschland GmbH and Unicyte AG. Her expertise in the field has allowed her to contribute to innovative research and development projects that focus on regenerative medicine and cellular therapies.
Collaborations
Maria has collaborated with esteemed colleagues, including Giovanni Camussi and Vincenzo Cantaluppi. These partnerships have further enriched her research and expanded the impact of her inventions in the scientific community.
Conclusion
Maria Chiara Deregibus stands out as a leading inventor in the field of extracellular vesicle research. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.